Form D Explorer
Qlaris Bio, Inc. · CIK 1786717

Report a data issueCitable research briefCompare issuerPrivate research collection

Qlaris Bio, Inc.

CIK 1786717 · Corporation · Inc. DELAWARE · Dedham, Massachusetts · Biotechnology
Sign up to follow Sign in for contact lookup
Filings
2
Original notices
2
Amendments
0
Activity
Nov 17, 2025
through Jun 17, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldNov 17, 2025 · DJun 17, 2026 · DLater minus earlier
Reported offering amount$5,641,600$3,946,659$-1,694,941
Reported amount sold$5,641,600$3,946,659$-1,694,941
Reported investor count—8—
Reported minimum investment$0$0$0

Earlier SEC source: 0001786717-25-000002 · Later SEC source: 0001786717-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Jun 17, 2026

Reported offering amount
$3,946,659
Reported exemptions
Rule 506(b)
Reported amount sold
$3,946,659

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)